Squamous Cell Skin Carcinoma in Systemic Lupus Erythematosus: Case Report and Literature Review
https://doi.org/10.20514/2226-6704-2020-10-5-390-397
Abstract
The case report of squamous cell skin carcinoma diagnosed in a patient with systemic lupus erythematosus 26 years after the onset of rheumatic disease is presented. The features of this case included the absence of skin manifestations of systemic lupus erythematosus, the occurrence of a tumor at the site of ulcers and trophic disorders on the leg, a long period (6 years) from the onset of a ulcerative defect on the leg to the diagnosis of skin cancer (despite multiple biopsies and consultations of various specialists), as well as the occurrence of a cytokine release syndrome, which directly led to the death of the patient after the first use of the immune checkpoint inhibitors. Possible causes of skin cancer in patients with systemic lupus erythematosus, as well as the features of the cytokine release syndrome after immunotherapy for oncological diseases, are discussed.
About the Author
S. V. Topolyanskaya
I.M. Sechenov First Moscow State Medical University (Sechenov University), RF Health Ministry
Russian Federation
Russian Federation
Svetlana V. Topolyanskaya - Hospital Therapy Department № 2
Moscow
References
1. Song L., Wang Y., Zhang J., et al. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and metanalysis. Arthritis Research & Therapy. 2018;20(1):270. doi:10.1186/s13075-018-1760-3.
2. Squamous cell carcinoma of the skin. Clinical guidelines. 2020. [Electronic resource]. URL: https://oncology-association.ru/files/newclinical-guidelines/ploskokletochnyj_rak_kozhi.pdf. (date of the application: 22.07.2020). [In Russian].
3. Zaalberg A., Tuchayi S.M., Ameri A.H., et al. Chronic inflammation promotes skin carcinogenesis in cancer-prone discoid lupus erythematosus. J Invest Dermatol. 2019;139(1):62-70. doi:10.1016/j.jid.2018.06.185.
4. Bhat M.R., Hulmani M., Dandakeri S., et al. Disseminated discoid lupus erythematosus leading to squamous cell carcinoma. Indian J Dermatol. 2012;57(2):158-161. doi:10.4103/0019-5154.94298
5. Combemale P., Bousquet M., Kanitakis J., et al. Malignant transformation of leg ulcers: a retrospective study of 85 cases. J Eur Acad Dermatol Venereol. 2007;21(7):935-941. doi: 10.1111/j.1468-3083.2006.02118.x.
6. Ceschi A., Noseda R., Palin K., et al. Immune Checkpoint Inhibitor- Related Cytokine Release Syndrome: Analysis of WHO Global Pharmacovigilance Database. Front. Pharmacol. 2020;11:557. doi: 10.3389/fphar.2020.00557.
7. Shimabukuro-Vornhagen A., Gödel P., Subklewe M., et al. Cytokine release syndrome. J Immunother Cancer. 2018;6:56. doi:10.1186/s40425-018-0343-9.
8. Tisoncik J.R., Korth M.J., Simmons C.P., et al. Into the Eye of the Cytokine Storm. Microbiol Mol Biol Rev. 2012;76(1):16-32. doi: 10.1128/MMBR.05015-11.
9. Wang J., Jiang M., Chen X., Montaner L.J. Cytokine storm and leukocyte changes in mild versus severe SARSCoV-2 infection. Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020: 10.1002/GLB.3COVR0520-272R. doi: 10.1002/JLB.3COVR0520272R
Review
For citations:
Topolyanskaya S.V. Squamous Cell Skin Carcinoma in Systemic Lupus Erythematosus: Case Report and Literature Review. The Russian Archives of Internal Medicine. 2020;10(5):390-397. https://doi.org/10.20514/2226-6704-2020-10-5-390-397
Views:
2072
Email this article 